Department of Nursing, Tabas Branch Islamic Azad University, Tabas, Iran.
Department of Nursing, Faculty of Nursing and Midwifery, Sabzevar University of Medical Sciences, Sabzevar, Iran.
J Complement Integr Med. 2021 Aug 30;19(4):1007-1012. doi: 10.1515/jcim-2021-0126. eCollection 2022 Dec 1.
Acute myocardial infarction (MI) and hospitalization are one of the most stressful situations for many patients. Aromatherapy is a branch of the complementary medicine that is effective in anxiety. The present study aims to determine the effect of aromatherapy with rose essential oil (REO) on apparent anxiety in patients with acute MI.
This randomized clinical trial was carried out on patients with acute MI admitted to the cardiac ward of Heshmatieh Hospital in Sabzevar. Eighty patients were randomly assigned to two aromas and placebo groups, who received three drops of REO or placebo by inhalation three times a day for 3 days. Before and after the intervention, patients' anxiety levels were measured by the Spielberger questionnaire. Data were analyzed by chi-square and the independent and paired and t-tests.
Before the intervention, the mean of apparent anxiety was not significantly different in the intervention and control groups (48.44 ± 3.81 and 51.38 ± 7.21, respectively, p=0.16) while this parameter was significant after the intervention in both experimental groups (47.27 ± 7.11 and 44.16 ± 4.63, respectively, p=0.000), with a reduction in the mean of apparent anxiety in the intervention group. Moreover, the results of paired t-test revealed that the anxiety scores decreased significantly in the test group before and after the intervention (51.38 ± 7.21 and 44.16 ± 4.63, p=0.000).
Considering the positive effects of REO used in this study to reduce anxiety in patients with acute MI, the use of REO is recommended as a complementary treatment to reduce anxiety in these patients.
急性心肌梗死（MI）和住院是许多患者最紧张的情况之一。芳香疗法是补充医学的一个分支，对焦虑有效。本研究旨在确定玫瑰精油（REO）的芳香疗法对急性 MI 患者明显焦虑的影响。
这是一项在萨布泽瓦尔 Heshmatieh 医院心脏病房住院的急性 MI 患者中进行的随机临床试验。将 80 名患者随机分为两组，每组 40 人，分别接受三滴 REO 或安慰剂通过吸入，每天 3 次，持续 3 天。在干预前后，使用 Spielberger 问卷测量患者的焦虑水平。采用卡方检验、独立样本 t 检验和配对样本 t 检验对数据进行分析。
干预前，干预组和对照组的明显焦虑均值无显著差异（分别为 48.44±3.81 和 51.38±7.21，p=0.16），但干预后两组均显著降低（分别为 47.27±7.11 和 44.16±4.63，p=0.000），干预组的明显焦虑均值降低。此外，配对 t 检验结果表明，试验组干预前后焦虑评分显著降低（分别为 51.38±7.21 和 44.16±4.63，p=0.000）。
考虑到 REO 在本研究中对减轻急性 MI 患者焦虑的积极作用，建议将 REO 作为一种辅助治疗方法，用于减轻这些患者的焦虑。
